Skip to main content
. Author manuscript; available in PMC: 2017 Dec 18.
Published in final edited form as: Ann Surg Oncol. 2015 Aug 20;23(2):655–662. doi: 10.1245/s10434-015-4778-7

FIG. 3.

FIG. 3

Complement inhibition with SSL7 results in increased tumor infiltration of effector T cells via increased production of chemoattractive mediators. a Using complement inhibitor, SS7, similar effects on tumor infiltrating lymphocytes were found with increased percentage of CD8+ cells in SSL7-treated mice (p = 0.004). b Trend was exhibited toward decreased infiltration of CD4+ cells in SSL7-treated mice compared to controls (p = 0.06)